Skip to content
MarketScale
‹ Back to IndustriesHealthcare

A Military Veteran’s Advice on Leadership in Healthcare? Build Leader Resiliency to Reduce Burnout

The future of healthcare leadership is a conversation that’s becoming increasingly crucial. The healthcare industry faces unprecedented challenges in the wake of the ongoing COVID-19 pandemic. It’s a time when leadership needs to be reimagined, particularly in an industry where burnout and compassion fatigue are rife among front-line workers. Estimates indicate 60% of healthcare…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Holistic Leadership on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

The future of healthcare leadership is a conversation that’s becoming increasingly crucial. The healthcare industry faces unprecedented challenges in the wake of the ongoing COVID-19 pandemic. It’s a time when leadership needs to be reimagined, particularly in an industry where burnout and compassion fatigue are rife among front-line workers. Estimates indicate 60% of healthcare workers reported burnout during the height of the pandemic. This fatigue continues to cause healthcare workers to leave the field, creating a gap in an industry whose needs are growing, not shrinking.

Considering these staggering figures, how can leadership in healthcare evolve to combat these challenges, foster resilience, and adapt to the changing landscape of this crucial sector?

In the latest episode of Holistic Leadership, The Future of Work & Education in Healthcare, hosted by Travis Hearne, we dive into this pertinent discussion with Dr. Kathleen Flarity, a veteran healthcare and military leader with more than four decades of service.

In this episode, the conversation revolves around three main areas:

  • The link between healthcare provider resiliency and leader resiliency and how fostering these can mitigate the risks of burnout and compassion fatigue
  • The balance between individual responsibility and organizational responsibility in healthcare leadership, particularly in the context of addressing systemic burnout
  • The evolution of Dr. Flarity’s mission and calling for leaders in the healthcare space, informed by her unique experiences in both healthcare and the military

Dr. Kathleen Flarity is a highly decorated military veteran, an esteemed academic, and a pioneer in healthcare. Her esteemed career includes serving as Deputy Director of the University of Colorado Anschutz Center for Combat Medicine and Battlefield Research and the role of Air Force Brigadier General.

Beyond her military service, Dr. Flarity has published over 16 book chapters and 32 journal articles, including 15 peer-reviewed research manuscripts. She has significantly contributed to the healthcare field as an associate clinical professor of emergency medicine at the University of Colorado Denver Anschutz Medical Campus and the President of the Aerospace Nursing and Allied Health Professional Society.

She is also the president and founder of Flarity Consulting LLC, specializing in leadership consulting and re-engineering clinical processes. Her unique insights and experiences make her an authoritative voice in the evolving discussion around healthcare leadership.

Holistic Leadership

Part of this channel

Holistic Leadership

Healthcare leadership grounded in culture, well-being, and practical growth.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

The FDA approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for multiple inflammatory diseases, which means it may be substituted without consulting the prescriber, subject to state pharmacy laws. A Springer analysis reported 26 interchangeable biosimilars approved since 2020 and said average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024. The operational pressure shifts to formulary, payer, and specialty pharmacy workflow design.

  • 01Interchangeability is becoming the default ask, not an afterthought: Springer found 17 of 26 approvals pursued interchangeability concurrently, which changes how buyers should time contracting and conversions.
  • 02Springer reported average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024, which can compress planning windows for monitoring and implementation.
  • 03A new interchangeable ustekinumab option means the hard work is no longer clinical, it is operational: NDC mapping, EMR preference lists, substitution rules by state, and patient communications decide whether savings show up.

Sep 8, 2026

AAO-HNSF hearing loss guideline moves audiograms and amplification into primary care

AAO-HNSF’s new age-related hearing loss guideline calls for screening adults starting at age 50 and escalating to otoscopy, audiogram, and appropriately fit amplification. It shifts hearing loss from “patient complaint” to a routine primary-care workflow. The pressure shows up in audiology capacity, referral design, and documentation standards.

  • 01Screening at age 50 becomes a repeatable workflow, so capacity planning shifts from episodic ENT referrals to steady primary-care volume, especially where annual wellness visits are a dominant access point.
  • 02The guideline’s escalation sequence, screen, otoscopy, audiogram, amplification, then cochlear implant candidacy evaluation, creates a measurable funnel that health systems can instrument in the EHR and manage like any other pathway.
  • 03Asymmetric loss remains a separate trigger for MRI in many settings, and 2026 pre-proof work using NHANES and SEER highlights why imaging criteria choices can swing scan volume, a budgeting and radiology access issue, not a clinical footnote.

Sep 7, 2026

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

Accenture will keep supporting Australia’s My Health Record under a new three-year contract. ADHA is moving the platform to a multi-supplier operating model. The shift raises questions about shared integration discipline, tooling, and accountability when changes hit production.

  • 01Multi-supplier delivery is spreading across national-scale health platforms, as ADHA's My Health Record shift shows, moving risk from vendor selection to integration, runbooks, and accountability.
  • 02GenAI model upgrades are arriving with healthcare-specific claims, but the procurement work moves to evidence, safety controls, and monitoring once models sit inside clinical workflows.
  • 03Embedded AI expands the cyber asset inventory problem: if teams cannot discover the AI components across endpoints and devices, they cannot reliably secure or audit them.

Sep 7, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512